Bettini, S., Bordigato, E., Milan, G., Dal Pra', C., Favaretto, F., Belligoli, A., . . . Fabris, R. (2019). SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy. Obes Facts.
Chicago Style CitationBettini, Silvia, et al. "SCCA-IgM As a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients With Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy." Obes Facts 2019.
Cita MLABettini, Silvia, et al. "SCCA-IgM As a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients With Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy." Obes Facts 2019.
Atenció: Aquestes cites poden no estar 100% correctes.